DMK PHARMACEUTICALS
$0
121
+$0+0% Thursday 21:00
Statistics
Day High
0
Day Low
0
52W High
0
52W Low
0
Volume
2
Avg. Volume
2,822
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Earnings
22NovExpected
Expected EPS
-0.2
Actual EPS
N/A
Financials
-556.73%Profit Margin
Unprofitable4.76MRevenue
-26.48MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow DMKPQ. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
DMK Pharmaceuticals Corporation, a clinical stage neuro-biotechnology company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory diseases. The company's lead clinical stage product candidate, DPI-125, which is indicated for the treatment of opioid use disorder. Its products include SYMJEPI epinephrine injection for the emergency treatment of allergic reactions to stinging and biting insects, allergen immunotherapy, foods, drugs, diagnostic testing substances, and other allergens, as well as idiopathic or exercise-induced anaphylaxis; and ZIMHI naloxone injection for the treatment of opioid overdose. The company was formerly known as Adamis Pharmaceuticals Corporation and changed its name to DMK Pharmaceuticals Corporation in September 2023. The company is headquartered in San Diego, California. On February 2, 2024, DMK Pharmaceuticals Corporation, along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Show more...
CEO
Mr. Seth Abraham Cohen
Employees
11
Country
US
Listings
0 Comments
Share your thoughts
FAQ
What is DMK PHARMACEUTICALS stock price today?▼
The current price of DMKPQ is $0 USD — it has increased by +0% in the past 24 hours. Watch DMK PHARMACEUTICALS stock price performance more closely on the chart.
What is DMK PHARMACEUTICALS stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange DMK PHARMACEUTICALS stocks are traded under the ticker DMKPQ.
Is DMK PHARMACEUTICALS stock price growing?▼
DMKPQ stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year DMK PHARMACEUTICALS has showed a +0% increase.
What is DMK PHARMACEUTICALS revenue for the last year?▼
DMK PHARMACEUTICALS revenue for the last year amounts to 4.76M USD.
What is DMK PHARMACEUTICALS net income for the last year?▼
DMKPQ net income for the last year is -26.48M USD.
How many employees does DMK PHARMACEUTICALS have?▼
As of April 02, 2026, the company has 11 employees.
When did DMK PHARMACEUTICALS complete a stock split?▼
The last stock split for DMK PHARMACEUTICALS was on December 13, 2013 with a ratio of 1:17.
Where is DMK PHARMACEUTICALS headquartered?▼
DMK PHARMACEUTICALS is headquartered in San Diego, US.